Literature DB >> 21353577

Development of a Tandem-Electrostatic-Quadrupole facility for Accelerator-Based Boron Neutron Capture Therapy.

A J Kreiner1, W Castell, H Di Paolo, M Baldo, J Bergueiro, A A Burlon, D Cartelli, V Thatar Vento, J M Kesque, J Erhardt, J C Ilardo, A A Valda, M E Debray, H R Somacal, J C Suarez Sandin, M Igarzabal, H Huck, L Estrada, M Repetto, M Obligado, J Padulo, D M Minsky, M Herrera, S J Gonzalez, M E Capoulat.   

Abstract

We describe the present status of an ongoing project to develop a Tandem-ElectroStatic-Quadrupole (TESQ) accelerator facility for Accelerator-Based (AB)-BNCT. The project final goal is a machine capable of delivering 30 mA of 2.4 MeV protons to be used in conjunction with a neutron production target based on the (7)Li(p,n)(7)Be reaction. The machine currently being constructed is a folded TESQ with a high-voltage terminal at 0.6 MV. We report here on the progress achieved in a number of different areas. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21353577     DOI: 10.1016/j.apradiso.2011.01.040

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

1.  Present status of Accelerator-Based BNCT.

Authors:  Andres Juan Kreiner; Javier Bergueiro; Daniel Cartelli; Matias Baldo; Walter Castell; Javier Gomez Asoia; Javier Padulo; Juan Carlos Suárez Sandín; Marcelo Igarzabal; Julian Erhardt; Daniel Mercuri; Alejandro A Valda; Daniel M Minsky; Mario E Debray; Hector R Somacal; María Eugenia Capoulat; María S Herrera; Mariela F Del Grosso; Leonardo Gagetti; Manuel Suarez Anzorena; Nicolas Canepa; Nicolas Real; Marcelo Gun; Hernán Tacca
Journal:  Rep Pract Oncol Radiother       Date:  2014-12-12

2.  Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy.

Authors:  Eisuke Sato; Alexander Zaboronok; Tetsuya Yamamoto; Kei Nakai; Sergey Taskaev; Olga Volkova; Ludmila Mechetina; Alexander Taranin; Vladimir Kanygin; Tomonori Isobe; Bryan J Mathis; Akira Matsumura
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.